BLFS
Price
$25.35
Change
+$0.30 (+1.20%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
1.2B
65 days until earnings call
CERS
Price
$1.27
Change
-$0.04 (-3.05%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
251.13M
58 days until earnings call
Interact to see
Advertisement

BLFS vs CERS

Header iconBLFS vs CERS Comparison
Open Charts BLFS vs CERSBanner chart's image
BioLife Solutions
Price$25.35
Change+$0.30 (+1.20%)
Volume$10.56K
Capitalization1.2B
Cerus
Price$1.27
Change-$0.04 (-3.05%)
Volume$20.2K
Capitalization251.13M
BLFS vs CERS Comparison Chart in %
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. CERS commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and CERS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (BLFS: $25.05 vs. CERS: $1.31)
Brand notoriety: BLFS and CERS are both not notable
BLFS represents the Pharmaceuticals: Other, while CERS is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BLFS: 66% vs. CERS: 53%
Market capitalization -- BLFS: $1.2B vs. CERS: $251.13M
BLFS [@Pharmaceuticals: Other] is valued at $1.2B. CERS’s [@Medical/Nursing Services] market capitalization is $251.13M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.67B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.89B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.98B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileCERS’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • CERS’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than CERS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 6 TA indicator(s) are bullish while CERS’s TA Score has 5 bullish TA indicator(s).

  • BLFS’s TA Score: 6 bullish, 4 bearish.
  • CERS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than CERS.

Price Growth

BLFS (@Pharmaceuticals: Other) experienced а -3.32% price change this week, while CERS (@Medical/Nursing Services) price change was +3.56% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.31%. For the same industry, the average monthly price growth was +8.56%, and the average quarterly price growth was +30.22%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.22%. For the same industry, the average monthly price growth was +3.25%, and the average quarterly price growth was +13.40%.

Reported Earning Dates

BLFS is expected to report earnings on Nov 06, 2025.

CERS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.31% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (-0.22% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($1.2B) has a higher market cap than CERS($251M). BLFS YTD gains are higher at: -3.505 vs. CERS (-14.935). BLFS has higher annual earnings (EBITDA): 17.4M vs. CERS (-8.62M). BLFS (81.8M) and CERS (78M) have equal amount of cash in the bank . BLFS has less debt than CERS: BLFS (23.8M) vs CERS (98.9M). CERS has higher revenues than BLFS: CERS (193M) vs BLFS (93.5M).
BLFSCERSBLFS / CERS
Capitalization1.2B251M478%
EBITDA17.4M-8.62M-202%
Gain YTD-3.505-14.93523%
P/E RatioN/AN/A-
Revenue93.5M193M48%
Total Cash81.8M78M105%
Total Debt23.8M98.9M24%
FUNDAMENTALS RATINGS
BLFS vs CERS: Fundamental Ratings
BLFS
CERS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
39
Fair valued
PROFIT vs RISK RATING
1..100
91100
SMR RATING
1..100
9297
PRICE GROWTH RATING
1..100
4863
P/E GROWTH RATING
1..100
14100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (39) in the Medical Specialties industry is somewhat better than the same rating for BLFS (99). This means that CERS’s stock grew somewhat faster than BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (91) in the Medical Specialties industry is in the same range as CERS (100). This means that BLFS’s stock grew similarly to CERS’s over the last 12 months.

BLFS's SMR Rating (92) in the Medical Specialties industry is in the same range as CERS (97). This means that BLFS’s stock grew similarly to CERS’s over the last 12 months.

BLFS's Price Growth Rating (48) in the Medical Specialties industry is in the same range as CERS (63). This means that BLFS’s stock grew similarly to CERS’s over the last 12 months.

BLFS's P/E Growth Rating (14) in the Medical Specialties industry is significantly better than the same rating for CERS (100). This means that BLFS’s stock grew significantly faster than CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSCERS
RSI
ODDS (%)
Bearish Trend 5 days ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 5 days ago
79%
Bullish Trend 5 days ago
73%
Momentum
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 5 days ago
78%
MACD
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 5 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
74%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 8 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 5 days ago
86%
Aroon
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 5 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AICOF0.16N/A
+0.10%
Generative AI Solutions Corp.
BYLB94.520.01
+0.01%
Boyle Bancorp, Inc.
SHLRF354.00N/A
N/A
Schindler Holding AG
KCDMY9.42-0.09
-0.95%
Kimberly-Clark de Mexico, S.A.B de C.V.
AMGDF0.99-0.03
-2.49%
Aston Martin Lagonda Global Holdings plc.

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+0.52%
RGEN - BLFS
59%
Loosely correlated
+0.12%
A - BLFS
51%
Loosely correlated
+0.56%
RVTY - BLFS
50%
Loosely correlated
+0.99%
TWST - BLFS
49%
Loosely correlated
+1.43%
AZTA - BLFS
49%
Loosely correlated
+2.07%
More

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with UTMD. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then UTMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
N/A
UTMD - CERS
45%
Loosely correlated
+0.24%
BLFS - CERS
45%
Loosely correlated
+0.52%
NNOX - CERS
44%
Loosely correlated
-0.26%
CLPT - CERS
44%
Loosely correlated
N/A
LAB - CERS
43%
Loosely correlated
-2.33%
More